Disclosed is a pharmaceutical composition comprising a) a homeopathic activated-potentiated form of an antibody to prostate-specific antigen, and b) a homeopathic activated-potentiated form of an antibody to endothelial NO-synthase. Also disclosed is the use of such a pharmaceutical composition in the preparation of a medicament for the treatment of benign prostatic hyperplasia.